What's new

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised

May 20, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Trump administration lays out more details of plan to lower drug prices

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib...

Related Posts

Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Human medicines European public assessment report (EPAR): Xyrem, sodium oxybate, Date of authorisation: 13/10/2005, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0